Cited by — Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications.
No admitted local citation edges point to this work yet.
